Results 231 to 240 of about 365,810 (316)

Epidemiological Trends in the Characterization of Human Papillomavirus Virus-Related Oropharyngeal Cancer: A Global Perspective. [PDF]

Curr Oncol Rep
Chen AM.
europepmc   +1 more source

Effect of a Home‐Based Exercise Program on Muscle Mass, Fatigue, and Health‐Related Quality of Life Among Patients with Oral Cancer: A Randomized Trial

Head &Neck, Volume 48, Issue 3, Page 680-695, March 2026.
ABSTRACT Background Patients with head and neck cancer (HNC) often experience deteriorated health‐related quality of life (HRQoL) and loss of body weight and muscle mass. The primary aim was to determine if a home‐based exercise program, aiming to increase physical activity (PA), could reduce muscle mass loss and fatigue.
Camilla Wallmander, Ingvar Bosaeus, Ewa Silander, Hedda Haugen Cange, Jan Nyman, Monika Fagevik Olsén, Elisabet Blomsterwall, Malin Berg, Eva Hammerlid   +8 more
wiley   +1 more source

Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study. [PDF]

Arthritis Res Ther
Shen HC, Landon-Cardinal O, Bourré-Tessier J, Hoa S, Zarka F, Nehme J, Mansour AM, Makhzoum JP, Mereniuk A, Meunier RS, Bouchard-Marmen M, Poirier-Blanchette L, Landry M, Lévesque M, Massie R, Blanchard O, Lefebvre F, Goulet JR, Rich E, Raynauld JP, Pérez G, Koenig M, Allard-Chamard H, Drouin J, Chartrand S, Aaron M, Ivensky V, Infantino M, Giannini M, Betteridge Z, Leclair V, Hudson M, Karamchandani J, Hervier B, O'Ferrall E, Ellezam B, Targoff IN, Satoh M, Fritzler MJ, Senécal JL, Meyer A, Troyanov Y.   +41 more
europepmc   +1 more source

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

Head &Neck, Volume 48, Issue 3, Page 733-746, March 2026.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen, Allison Drosdowsky, Tsien F. Fua, Lachlan J. McDowell, Karla Gough   +4 more
wiley   +1 more source

FAM19A4 and miR124-2 methylation status in human papillomavirus-driven and human papillomavirus-negative oropharyngeal squamous cell carcinomas. [PDF]

Infect Agent Cancer
Donà MG, Giuliani E, Laquintana V, Covello R, Pellini R, Moretto S, Latini A, Benevolo M, Rollo F.   +8 more
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

Head &Neck, Volume 48, Issue 3, Page 837-842, March 2026.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen, Neil Gross, Marc‐Elie Nader, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Paul Gidley   +6 more
wiley   +1 more source

Biopsy for Suspicious Oral Lesions: A Review From the American Head and Neck Society‐Cancer Prevention Service

Head &Neck, Volume 48, Issue 3, Page 884-892, March 2026.
ABSTRACT Background Oral cancer is often preceded by a precursor lesion. This presents an opportunity for early diagnosis and intervention. Method of biopsy and interpretation are not well standardized and novel methods of analysis are now being investigated.
James Christopher Gates, Heather Edwards, Alessandro Villa, Nick Purdy, Michael Troka, Peter Varela, Quinn Self, Yingci Liu, Yusuf Dundar, Patricia Joyce Brooks, Dauren Adilbay, Andrew Birkeland, John Cramer   +12 more
wiley   +1 more source

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study. [PDF]

J Cancer
Geng X, Zhao Y, Wu Y, Ma X, Xia R, Xu X, Ren G.   +6 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, Volume 183, Issue 6, Page 1250-1270, March 2026.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Oncologic Outcomes of Transoral Robotic Surgery in HPV-Associated OPSCC: A Systematic Review and Meta-Analysis. [PDF]

Otolaryngol Head Neck Surg
Cheung MH, Kim CH, Nguyen SA, Williamson L, Kejner A, Bobian M, Newman JG.   +6 more
europepmc   +1 more source